Comments for Rigel Pharmaceuticals, Inc.'s R788 Significantly Improves Rheumatoid Arthritis In Phase 2b Clinical Trial at http://www.biomedreports.com http://www.biomedreports.com Wed, 08 Feb 2012 17:06:44 +0100 FeedCreator 1.7.3